You are here

  • Home
  • Archive
  • Volume 28, Issue Suppl 1
  • 4CPS-277 Cetuximab versus bevacizumab in metastatic colorectal cancer: a comparative effectiveness and patient reported outcomes multi-cohort study

Article metrics

Article menu

Download PDFPDF

Section 4: Clinical pharmacy services
4CPS-277 Cetuximab versus bevacizumab in metastatic colorectal cancer: a comparative effectiveness and patient reported outcomes multi-cohort study
Free

 

Online download statistics by month:

Online download statistics by month: March 2021 to September 2024

AbstractFullPdf
Mar 202122013
Apr 20214904
May 2021303
Jun 2021001
Jul 2021103
Aug 2021105
Sep 2021104
Oct 202113022
Nov 20216016
Dec 202139010
Jan 20221403
Feb 20222102
Mar 2022501
Apr 20221403
May 202215011
Jun 2022603
Jul 2022400
Aug 2022602
Sep 20222106
Oct 2022405
Nov 20221402
Dec 20221201
Jan 20231503
Feb 20231001
Mar 20231003
Apr 2023903
May 2023001
Jun 2023001
Jul 2023603
Aug 2023604
Sep 20231205
Oct 20231401
Nov 20231504
Dec 20231900
Jan 20241601
Feb 20241203
Mar 20248015
Apr 2024709
May 2024600
Jun 2024800
Jul 2024503
Aug 2024801
Sep 20241803
Total4750184